Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07726953) titled 'Full-Course ECMO Strategy for Moderate-to-Severe ARDS' on July 21.

Study Type: Interventional

Study Design: Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Southeast University, China

Condition: Acute Respiratory Distress Syndrome

Intervention: Other: Full-Course ECMO Management Pathway

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: June 16, 2026

Target Sample Size: 500

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07726953

Published by HT Digit...